Hair loss medications can affect men’s sexual health
March 8th, 2011 - 1:28 pm ICT by ANIWashington, March 08 (ANI): A new study has shown that 5a-reductase inhibitors, commonly used to treat urinary problems in patients with benign prostatic hyperplasia (BPH) and found in popular medications to treat hair loss, can produce, persistent erectile dysfunction (ED), depression and loss of libido, even after the medication has been discontinued.
Researchers, led by Abdulmaged M. Traish, of Boston University School of Medicine, examined data reported in various clinical studies from the available literature concerning the side effects of the 5 alpha reductase inhibitors, finasteride and dutasteride.
Prolonged adverse side effects on sexual function, such as ED, depression and diminished libido, were reported by a subset of men. Drug-related reduction in libido occurred in 4.2 pc and 1.8 pc of patients in the dutasteride and placebo groups, respectively. Reduced ejaculation and semen volume were also reported and in some patients, these drugs were associated with depression.
Dr. Irwin Goldstein, editor-in-chief of The Journal of Sexual Medicine, has seen and evaluated numerous such patients. He further explained the importance of this study.
“Young men are being prescribed 5 alpha reductase inhibitors as hair loss treatments that may negatively impact their sexual life, possibly for a prolonged time after stopping the medication. Older men with symptoms of lower urinary tract symptoms or fearful of prostate cancer, now have to deal with new onset sexual and mental health problems. The growing use of 5 alpha reductase inhibitors is causing concerns.”
The study has been published in the Journal of Sexual Medicine. (ANI)
- Popular drugs could trip sex drive - Mar 08, 2011
- Hair loss drug may result in loss of libido in men - Jan 12, 2011
- Common hair loss drugs 'may impair men's sexual health' - Mar 19, 2011
- Combo therapy for enlarged prostate more effective - Mar 03, 2010
- Surgery for benign prostatic hyperplasia offers more relief than drug therapy - May 30, 2010
- Device boosts libido of men with heart failure - Jun 02, 2011
- PSA test more reliable in men taking prostate-shrinking drug - Dec 18, 2010
- Heart disease may be linked to prostate cancer - Feb 09, 2012
- Hamster study shows cholesterol-lowering drug shrinks enlarged prostates - Oct 22, 2010
- Depressed men with erectile dysfunction face cardio problems - Jul 13, 2010
- Erectile dysfunction drug could help treat bladder outlet symptoms - Apr 27, 2009
- Testosterone therapy can overcome male menopause - Oct 03, 2011
- Steroid hormone deficiency may be behind cardiovascular disease - Sep 26, 2009
- Physical symptoms prevalent in all types of cancers regardless of stage - Oct 12, 2010
- Sleepy child? Factor in obesity, asthma - May 17, 2011
Tags: 5 alpha reductase, benign prostatic hyperplasia, benign prostatic hyperplasia bph, boston university school, boston university school of medicine, dr irwin, dutasteride, hair loss medications, hair loss treatments, irwin goldstein, loss of libido, lower urinary tract symptoms, mental health problems, placebo groups, prostate cancer, reductase inhibitors, sexual life, sexual medicine, urinary problems, urinary tract symptoms